Testosterone Propionate 100 Hima Biocare 10 ml

Testosterone Propionate 100mg/ml by Hilma Biocare

This 10ml pharmaceutical vial contains testosterone propionate 100mg/ml—a controlled injectable substance designed exclusively for medical use under direct professional supervision. The propionate ester provides a short activity window that supports precise therapeutic management and stable compound levels through regular administration protocols.

Product Specifications

• Testosterone Propionate: 100mg per milliliter
• Vial Volume: 10ml pharmaceutical-grade container
• Ester Type: Short-chain propionate ester
• Half-Life: 1-1.5 days
• Anabolic/Androgenic Rating: 100/100
• Manufacturing Standard: European pharmaceutical compliance

Mechanism of Action

Testosterone propionate is a short-acting ester that differs significantly from longer-acting formulations. Extended esters such as enanthate and cypionate require prolonged saturation and clearance periods; propionate achieves therapeutic levels more rapidly due to its shorter activity window. This pharmacological profile necessitates frequent dosing schedules and enables more responsive protocol modifications under medical supervision.

Medical Use

This product is strictly intended for medical use under direct professional medical supervision. Treatment protocols must be established and monitored by qualified healthcare providers. Proper clinical training and ongoing medical guidance are essential requirements before and during use.

Quality Assurance

Hilma Biocare maintains strict European pharmaceutical manufacturing standards throughout production. Each vial is formulated for sterility, concentration accuracy, and pharmaceutical integrity, meeting professional medical product requirements.

Storage and Handling

Store in a cool environment away from direct light and heat sources. Standard pharmaceutical injectable protocols apply—maintain aseptic technique and follow established safety procedures for all handling and administration.

Medical Professional Advantages

The short half-life enables rapid therapeutic adjustments when dose modification is clinically necessary. The balanced androgenic profile supports consistent physiological response, while the shorter duration facilitates individualized medical management under proper professional oversight.